Resistance to tumor necrosis factor-α-induced apoptosis in human T-lymphotropic virus type I-infected T cell lines
Journal
AIDS Research and Human Retroviruses
Journal Volume
18
Journal Issue
3
Pages
207-212
Date Issued
2002
Author(s)
Abstract
Induction of apoptosis of virus-infected cells is an important host cell defense mechanism. It is well documented that T cells may undergo apoptosis due to interactions between Fas and Fas ligand (FasL). In addition, signals that induce apoptosis in T cells can result from interaction of tumor necrosis factor (TNF)-α with TNF receptors (TNFRs). It has been shown that human T cell lines expressing HTLV-I have decreased sensitivity to Fas-mediated apoptosis. The susceptibility of HTLV-I-infected cells to TNF-α-induced apoptosis remains to be elucidated. In the present study, we examined the expression of TNFRs on HTLV-I-infected T cell lines that expressed T-cell activation markers and thus phenotypically resemble activated T cells. Different from primary activated T cells that expressed both TNFRs, none of the five HTLV-I-infected T cell lines studied had detectable TNFR1 and only three had TNFR2 on their cell surfaces, although, the RNA transcripts of both TNFR genes could be detected via reverse transcription-polymerase chain reaction in these cell lines. The T cell blasts, which we activated in vitro, were sensitive to apoptosis induced by TNF-α and by antibodies to TNFR1 and/or TNFR2. However, all of the HTLV-I-infected cell lines expressing TNFR2 were resistant to TNF-α-mediated apoptosis. These findings suggest that HTLV-I infection may interfere with the autonomous suicide programs of T cells, not only Fas/FasL but also TNFRs/TNF-α pathways, to prolong the life of the infected cells. This may contribute to viral persistence and favor survival and subsequent expansion of dysregulated infected T cells with the potential to produce HTLV-I-associated autoimmune-like diseases or malignancies.
SDGs
Other Subjects
cell marker; Fas antibody; FAS ligand; tumor necrosis factor; tumor necrosis factor alpha receptor; tumor necrosis factor receptor; apoptosis; article; autoimmune disease; blast cell; cell line; cell survival; controlled study; defense mechanism; genetic transcription; host cell; human; human cell; Human T cell leukemia virus 1; in vitro study; malignant neoplastic disease; persistent virus infection; phenotype; priority journal; protein expression; protein protein interaction; regulatory mechanism; reverse transcription polymerase chain reaction; T lymphocyte; T lymphocyte activation; virus infection; Antigens, CD; Apoptosis; Cell Line; Drug Resistance; Human T-lymphotropic virus 1; Humans; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Receptors, Tumor Necrosis Factor, Type II; T-Lymphocytes; Tumor Necrosis Factor-alpha
Type
journal article